Table 2 Mean difference changes in glycometric index in individual AHCL models.

From: Impact of heatwaves on glycemic control in adults with type 1 diabetes using hybrid closed-loop systems

 

MM780G

(n = 96)

TSX2

(n = 71)

DBLG1

(n = 15)

CamAPS FX

(n = 11)

GMI, %

0.0 (−0.1 to 0.0; P = 0.52)

0.0 (−0.2 to 0.1; P = 0.19)

0.1 (−0.1 to 0.2; P = 0.29)

−0.1 (−0.2 to 0.1; P = 0.43)

TAR2, %

0.2 (−0.3 to 0.6; P = 0.57)

−0.6 (−1.4 to 0.2; P = 0.1)

0.0 (−2.3 to 2.3; P = 1.0)

−1.0 (−2.5 to 0.5; P = 0.17)

TAR1, %

−0.1 (−0.8 to 0.7; P = 0.55)

−0.2 (−1.5 to 1.2; P = 0.15)

0.9 (−1.6 to 3.4; P = 0.78)

−1.9 (−5.6 to 1.9; P = 0.08)

TIR, %

0.2 (−0.8 to 1.2; P = 0.7)

1.1 (−0.6 to 2.7; P = 0.19)

−1.6 (−4.8 to 1.5; P = 0.27)

2.7 (−2.1 to 7.5; P = 0.22)

TBR1, %

−0.1 (−0.3 to 0.2; P = 0.84)

−0.2 (0.4 to −0.1; P = 0.79)

−0.1 (−0.8 to 0.6; P = 0.43)

0.4 (−0.1 to 0.9; P = 0.27)

TBR2, %

0.0 (−0.1 to 0.1; P = 0.44)

−0.1 (−0.3 to 0.0; P = 0.15)

0.0 (−0.3 to 0.3; P = 1.0)

−0.3 (−0.7 to 0.2; P = 0.16)

VC, %

0.7 (−0.2 to 1.5; P = 0.1)

−1.2 (−2.1 to −0.3; P = 0.13)

−0.7 (−3.9 to 2.5; P = 0.63)

0.3 (−2.7 to 2.1; P = 0.76)

  1. Data are expressed in mean difference in change (95% confidence interval; P value). AHCL, advanced hybrid closed-loop; MM780G, Medtronic Minimed 780G; TSX2, Tandem t: Slim X2; DBLG1, Diabeloop G1; GMI, glucose management index; TAR2, time above range level 2 of interstitial glucose > 250 mg/dL (13.9 mmol/L); TAR1, time above range level 1 of interstitial glucose 180–250 mg/dL (10.0–13.9 mmol/L); TIR, time in range of interstitial glucose 70–180 mg/dL (3.9–10.0 mmol/L); TBR1, time below range level 1 of interstitial glucose 54–70 mg/dL (3.0–3.9 mmol/L); TBR2, time below range level 2 of interstitial glucose < 54 mg/dL (3.0 mmol/L); VC, variation coefficient.
Back to article page